<level>
  <type>section</type>
  <num>29-2701</num>
  <heading>PROVIDER PARTICIPATION (§ 29-2701)</heading>
  <level>
    <num>2701.1.</num>
    <text>A provider of pharmacy services shall be a licensed pharmacy. To participate in the District of Columbia’s Medicaid Program, the provider shall:</text>
    <text>Fully comply with any applicable District, state and federal laws or regulations governing the provision and reimbursement of pharmacy services; and</text>
    <level>
      <num>(b)</num>
      <text>Complete and sign the Medicaid Provider Agreement.</text>
    </level>
  </level>
  <level>
    <num>2701.2.</num>
    <text>As a condition of participation, the provider shall be required to comply with the following requirements:</text>
    <text>Perform prospective drug utilization review before dispensing each prescription. This shall include screenings for, but not limited to, the following:</text>
    <text>Therapeutic duplication;</text>
    <text>Drug-disease contraindications;</text>
    <text>Drug interactions;</text>
    <text>Incorrect dosage indication, or duration;</text>
    <level>
      <num>(5)</num>
      <text>Drug allergies; and</text>
    </level>
    <text>Abuse or misuse;</text>
    <text>Provide patient counseling on all matters which, in the provider’s professional judgment, shall be deemed significant, including:</text>
    <text>Name and/or description of the medication;</text>
    <text>Route, dosage form, and duration of therapy;</text>
    <text>Directions for use;</text>
    <text>Common side effects;</text>
    <text>Potential adverse reactions, contraindications;</text>
    <text>Storage; and</text>
    <text>Refill information; and</text>
    <text>Obtain, record, and maintain patient profiles including the following:</text>
    <text>Name, address, phone number, age and gender;</text>
    <text>Individual history (i.e., diseases, allergies, drug reactions);</text>
    <text>Comprehensive listing of medications; and</text>
    <text>Relevant comments.</text>
  </level>
  <level>
    <type>annotations</type>
    <level>
      <heading>SOURCE</heading>
      <text>Notice of Final Rulemaking published at 59 DCR 2298, 2300 (March 23, 2012).</text>
    </level>
  </level>
</level>